Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
This study highlights the potential benefits of early surgical intervention for patients with lobar intracerebral hemorrhages, demonstrating improved functional outcomes and reduced mortality rates compared to medical management alone.
Neurology April 16th 2024
Epoch Health
Researchers have uncovered a promising link between sulforaphane, a natural chemical in cruciferous vegetables, and improved outcomes in stroke treatment. This compound offers a novel approach to enhancing the effectiveness of existing therapies without the associated risk of bleeding.
Cardiology April 9th 2024
MDLinx
In the realm of stroke management, time and precision are paramount. The case of a man who developed aphasia due to an alleged lapse in timely medical intervention serves as a poignant reminder of the consequences of overlooking essential preventive measures and the significance of rapid response in stroke care.
Emergency Medicine March 19th 2024
Practical Neurology
The TASTE-SL trial presents compelling evidence that Sanbexin, a sublingual combination of edaravone and dexborneol, offers a significant improvement in recovery for acute ischemic stroke patients, marking a notable advancement in neuroprotective treatment strategies.
Neurology March 5th 2024
This study underscores the critical need for precise diagnostic criteria in treating unexplained strokes and the potential reevaluation of anticoagulant use in patients with atrial cardiopathy, opening new avenues for research and patient care.
Neurology February 13th 2024
In a recent trial, late administration of tenecteplase, from 4.5 to 24 hours post-stroke onset, did not demonstrate a significant advantage over placebo in improving the functional outcomes of patients, as measured by the modified Rankin scale at 90 days.